Latest Articles

Publication Date
Comparison of Efficacy and Safety of Rivaroxaban, Heparin, and Enoxaparin in Preventing Thrombosis in Gynaecologic Oncology Surgeries : Thromboprophylaxis in Gyn-oncology Surgery.

Background: Background: Venous thromboembolism (VTE) is a frequent and potentially serious complication following gynecologic oncology surgeries. Anticoagulants such as heparin, enoxaparin, and rivaroxaban are commonly used for thromboprophylaxis; however, their …

Published: Nov. 4, 2025, midnight
Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet? - ts2.tech

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet? ts2.tech

Published: Nov. 3, 2025, 2:12 p.m.
Triple meeting 2025 – early efficacy signs for Quanta | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Triple meeting 2025 – early efficacy signs for Quanta | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: Oct. 27, 2025, 3:49 p.m.
Frontline Strategy: Why You Must Use IO Upfront in Endometrial Cancer - Targeted Oncology

Frontline Strategy: Why You Must Use IO Upfront in Endometrial Cancer Targeted Oncology

Published: Oct. 22, 2025, 6:21 p.m.
Endometrial Cancer: Dostarlimab/Chemo Improves OS in Frontline RUBY Trial - Targeted Oncology

Endometrial Cancer: Dostarlimab/Chemo Improves OS in Frontline RUBY Trial Targeted Oncology

Published: Oct. 22, 2025, 5:11 p.m.
Association of white blood cell count to hemoglobin ratio with the life quality after laparoscopic surgery in patients with endometriosis.

Endometriosis (EM) is a common hormone-dependent and chronic inflammatory disease affecting women of reproductive age, characterized by pelvic pain, infertility, and reduced quality of life. Laparoscopic surgery is a primary …

Published: Oct. 13, 2025, midnight
Two Cases of Mesonephric-Like Adenocarcinoma Arising From Ovary and Peritoneal and Literature Review.

Reports of Mesonephric-like adenocarcinoma (MLA) arising from other than the ovary and uterus are exceedingly rare. This report details two cases of MLA in patients with a history of endometriosis. …

Published: Oct. 12, 2025, midnight
Poll Results Highlight Gynecologic Oncology Abstracts to Watch Ahead of ESMO 2025 - OncLive

Poll Results Highlight Gynecologic Oncology Abstracts to Watch Ahead of ESMO 2025 OncLive

Published: Oct. 10, 2025, 12:07 p.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 - BioSpace

Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 BioSpace

Published: Oct. 3, 2025, 10:53 a.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025 - JCN Newswire

Eisai Highlights Breadth of Oncology Research at ESMO 2025 JCN Newswire

Published: Oct. 3, 2025, 9:01 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!